Peter Klare
Impact in
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies
- Oncology top 2%
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- PARP inhibition in cancer therapy
- Colorectal Cancer Screening and Detection
Papers in
-
- Breast Cancer Treatment Studies 21
-
- Ovarian cancer diagnosis and treatment 13
- Co-authors
- Jalid Sehouli (13 shared papers)Werner Lichtenegger (10 shared papers)Dirk Stengel (6 shared papers)Oumar Camara (5 shared papers)Stefan von Delius (11 shared papers)Dirk Elling (5 shared papers)Roland Michael Schmid (10 shared papers)Harald Leo Sommer (4 shared papers)
In The Last Decade
Peter Klare
67 papers receiving 3.7k citations
Peter Klare's Hit Papers
Peers
Comparison fields: 5 of 75
- Cancer Research 1.8k
- Oncology 1.3k
- Reproductive Medicine 302
- Genetics 279
- Pulmonary and Respiratory Medicine 203
Countries citing papers authored by Peter Klare
This map shows the geographic impact of Peter Klare's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Klare with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Klare more than expected).
Fields of papers citing papers by Peter Klare
This network shows the impact of papers produced by Peter Klare. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Klare. The network helps show where Peter Klare may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Klare, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2–Positive and Triple-Negative Primary Breast Cancers Hit paper breakdown → | 2014 | 868 |
| 2 | Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial Hit paper breakdown → | 2014 | 810 |
| 3 | 2017 | 469 | |
| 4 | Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer Hit paper breakdown → | 2022 | 329 |
| 5 | 2018 | 220 | |
| 6 | 2020 | 121 | |
| 7 | 2008 | 112 | |
| 8 | 2018 | 94 | |
| 9 | Granulosa cell tumor of the ovary: 10 years follow-up data of 65 patients. | 2004 | 90 |
| 10 | 2007 | 70 | |
| 11 | 2016 | 60 | |
| 12 | 2018 | 43 | |
| 13 | 2021 | 39 | |
| 14 | 2002 | 29 | |
| 15 | 2007 | 29 | |
| 16 | 2006 | 27 | |
| 17 | 2016 | 25 | |
| 18 | 2019 | 22 | |
| 19 | 2021 | 21 | |
| 20 | 2017 | 19 |
About Peter Klare
Peter Klare is a scholar working on Cancer Research, Reproductive Medicine, Oncology, Anesthesiology and Pain Medicine and Pulmonary and Respiratory Medicine, having authored 68 papers that have together received 3.8k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (21 papers), Ovarian cancer diagnosis and treatment (13 papers), Colorectal Cancer Screening and Detection (5 papers), PARP inhibition in cancer therapy (5 papers), HER2/EGFR in Cancer Research (5 papers), Cancer Treatment and Pharmacology (4 papers), BRCA gene mutations in cancer (4 papers) and Anesthesia and Sedative Agents (3 papers). The work is most often cited by research in Cancer Research (1.8k citations), Oncology (1.3k citations), Reproductive Medicine (302 citations), Genetics (279 citations) and Pulmonary and Respiratory Medicine (203 citations). Peter Klare has collaborated with scholars based in Germany, Austria and Egypt. Frequent co-authors include Jalid Sehouli, Werner Lichtenegger, Dirk Stengel, Oumar Camara, Stefan von Delius, Dirk Elling, Roland Michael Schmid, Harald Leo Sommer, Guelten Oskay-Oezcelik and Alexander Mustea. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, Cancer Chemotherapy and Pharmacology, Journal of Clinical Oncology and Scandinavian Journal of Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.